Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06939218

Analysis of New Materials and Artificial Turf Products: Influence and Impact on Athlete Performance and Perception

This request pertains to a series of related projects on a common theme. Specifically, this set of projects aims to analyze the impact of new alternatives in materials and structures of artificial turf on athlete performance and perception, within the context of the elimination of microplastics as per Commission Regulation (EU) 2023/2055 of September 25, 2023. Third-generation sports artificial turf is notable for including performance infill (granules) that provide the necessary functionality and safety for sports practice. The vast majority of fields worldwide use materials that do not comply with the new European regulation, which has granted an eight-year moratorium. Therefore, there is little time to find new alternatives. The challenge lies not only in developing new structural solutions but also in understanding their impact on athletes. This issue is of high severity, as these sports facilities are the largest in terms of space and host the highest number of Physical Activity and Sports practitioners in Europe (mainly Football, Rugby, Hockey, and Padel).

For this reason, over the past year, the IGOID Group has requested various projects to cover all the necessary phases and nuances to address this issue.

The activities included in these projects are divided into two phases:

Phase 1: Evaluation of Sports Surfaces in the Laboratory (durability and surface-player and surface-ball interaction). Tests will be conducted on artificial turf samples constructed with SBR rubber (the main material to be replaced under the EU regulation), natural-origin infills, polymeric infills larger than 5 mm, and other infills. Initially, a market analysis and classification will be carried out, followed by laboratory tests. Across all projects, a minimum of 30 alternatives are expected to be analyzed.

Phase 2: Field Study. Tests will be conducted on a sample of athletes on constructed surfaces representing the different alternatives evaluated in Phase 1. Performance tests and a battery of assessments will be carried out to understand athlete perception. A sample of 30 athletes will be randomly divided into groups to perform different repetitions of the test batteries, covering a minimum of six different sports facilities.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

20 year–30 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Gender: Male or female football players. Experience: Players who have played football for at least one full season prior to participating in the study.

Playing Level: Players who have played at the base or amateur level for at least 6 years.

Health Status: Players who do not have active or chronic injuries that could affect their ability to perform performance tests.

Willingness to Participate: Players who are willing to undergo performance tests and complete perception questionnaires.

Recent Injury History: Players who have not experienced significant injuries in the three months prior to the start of the study.

Medical Conditions: Players who do not have pre-existing medical conditions that could affect their ability to perform performance tests or endanger their health during the tests.

Medication: Players who are not taking medications that could affect their ability to perform performance tests.

Consent: Players who have signed an informed consent form to participate in the study and are willing to consistently follow the study protocols.

Age: Players between 20 and 30 years old (to obtain a more homogeneous sample). -

Exclusion criteria

Recent Injury: Players who have experienced a significant injury in the last three months that required medical attention or could affect their ability to perform performance tests.

Chronic Illness: Players who have a chronic illness that could affect their ability to perform performance tests.

Medication: Players who are taking medications that could affect their ability to perform performance tests or could affect their understanding of the questionnaires and perception tools.

Medical History: Players who have a history of cardiovascular, pulmonary, or neurological disease.

Recent Surgery: Players who have had major surgery in the last six months that could affect their ability to perform performance tests.

Protocol Compliance: Players who are not willing or able to consistently follow the study protocols.

Disability: Players who have a physical or cognitive disability that could affect their ability to perform performance tests.

Consent: Players who have not signed an informed consent form to participate in the study.

Age: Players who do not meet the minimum and maximum age requirements to be included in the study.

-

Treatment and study plan

Countermovement Jump (CMJ)

Behavioral

Participants perform a vertical jump starting from a standing position, bending their knees to 90 degrees, and then jumping as high as possible. The height of the jump is measured using a laser measurement tool (OptoJump-Microgate, Optojump, Bolzano, Italy).

Repeated Jump Test

Behavioral

Participants perform repeated vertical jumps for 20 seconds, with the height of each jump measured using a laser measurement tool (OptoJump-Microgate, Optojump, Bolzano, Italy).

Repeated Sprint Ability (RSA) Test

Behavioral

articipants perform six 30-meter sprints with 20 seconds of rest between each sprint. Sprint times are measured using photocell timing gates (RaceTime, Microgate, Bolzano, Italy).

Maximum Sprint Test

Behavioral

Participants perform three maximum effort sprints over 40 meters. Sprint times and speeds are measured using 1080 motion analysis

Change of Direction (COD) Test

Behavioral

Participants perform a sprint with a change of direction, running 5 meters in one direction and then 5 meters at a 90-degree angle. The time to complete the test is measured.

Shooting Test

Behavioral

Participants perform a shooting test, aiming to hit a target with maximum speed. The speed of the shot is measured using radar.

Small side game test

Behavioral

Participants engage in a 5v5 small-sided game on a 600 m² field to simulate match conditions and assess performance in a game-like scenario.

Performance and Comfort Perception Questionnaire

Behavioral

Participants complete a questionnaire to assess their perception of performance and comfort on the surface, using a Visual Analogue Scale (VAS).

Perceived Exertion Questionnaire

Behavioral

Participants complete a questionnaire to assess their perceived exertion during the tests, using the Borg scale

Primary outcomes

  1. Performance Metrics on Different Surfaces

    Time frame: Sprint times: Measured at Baseline (Day 1) and Week 12. Jump heights: Measured at Baseline (Day 1) and Week 12. Agility: Measured at Baseline (Day 1) and Week 12.

    Sprint times (seconds): The time taken to complete a 20-meter sprint will be measured in seconds.

    Jump heights (meters): The height achieved during a vertical jump will be measured in meters.

    Agility (seconds): The time taken to complete an agility course will be measured in seconds.

  2. Perception of Comfort and Performance

    Time frame: Immediately after each testing session on each surface

    Participants' subjective ratings of comfort and performance on each surface using a Visual Analogue Scale (VAS).Scale Details: The VAS will range from 0 to 100 mm, where:

    0 mm represents the lowest possible rating (e.g., "No comfort" or "Poor performance").

    100 mm represents the highest possible rating (e.g., "Maximum comfort" or "Excellent performance").

    Interpretation of Scores: Higher scores on the VAS indicate better outcomes, meaning higher comfort and better performance.

Secondary outcomes

  1. Impact Absorption

    Time frame: Measured at Baseline (Day 1) during the initial evaluation of each surface.

    Measurement of impact absorption using the Artificial Athlete method (EN 14808: 2006). The results will be reported in kilonewtons (kN).

  2. Rotational Resistance

    Time frame: Measured at Baseline (Day 1) during the initial evaluation of each surface.

    Measurement of rotational resistance using a traction device with a dynamometric key (EN 15301-1: 2008 and FIFA 2015) in N·m

  3. Ball Rebound

    Time frame: Measured at Baseline (Day 1) during the initial evaluation of each surface.

    Measurement of ball rebound using a microphone (EN 12235: 2014 and FIFA 2015) in cm

  4. Ball Roll

    Time frame: Measured at Baseline (Day 1) during the initial evaluation of each surface.

    Measurement of horizontal ball roll using a standardized angle ramp and photocells (FIFA 2015). In cm

  5. Critical Fall Height

    Time frame: Measured at Baseline (Day 1) during the initial evaluation of each surface.

    Measurement of critical fall height using the Head Injury Criterion (HIC) (WR Regulation 22 2020) in cm

  6. Perceived Exertion

    Time frame: Immediately after each testing session on each surface.

    Participants' ratings of perceived exertion during the tests using the Borg scale. The Borg scale ranges from 6 to 20, where:

    6 represents "No exertion at all". 20 represents "Maximal exertion". Interpretation of Scores: Higher scores on the Borg scale indicate higher levels of perceived exertion.

  7. Vertical Deformation

    Time frame: Measured at Baseline (Day 1) during the initial evaluation of each surface.

    Measurement of vertical deformation using the Advanced Artificial Athlete method (FIFA 2015). The results will be reported in millimeters (mm).

Sponsors and collaborators

Lead sponsor

University of Castilla-La Mancha

Other

Registry information

Acronym: ANMATT

Important dates

Study start
2025
Primary completion
2025
Study completion
2026
First posted
Apr 22, 2025
Registry last updated
Apr 22, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.